VLA 1801
Alternative Names: Parvovirus B19 vaccine - Valneva; VLA-1801Latest Information Update: 19 May 2023
Price :
$50 *
At a glance
- Originator Valneva
- Class Viral vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Parvovirus infections